Providing a diverse range of perspectives from bullish to bearish, 7 analysts have published ratings on Vertex VERX in the last three months. The table below provides a snapshot of their recent ...

Providing a diverse range of perspectives from bullish to bearish, 7 analysts have published ratings on Vertex (NASDAQ:VERX) in the last three months. The table below provides a snapshot of their ...

If it wasn't obvious before, Latigo Biotherapeutics is all in on its non-opioid pain treatment pipeline and that is highlighted further by the company's $150 million Series B capital raise. Announced ...

Below is a table showing the current thinking of the analysts that cover Vertex Pharmaceuticals, Inc.: ...

We are the Artful Dodgers of the globalised world, experts at ducking and diving - but even the Dodger gets caught in the end ...

Direct-to-consumer (D2C) beauty and personal care company Pilgrim, based in Mumbai, has secured INR 200 crore, or roughly $23 ...

If you’re uncertain about various types of investment, you’re not alone. Let’s dive into the top investment categories for ...

AI is impacting all industries but none more than the publishing business model which lives or dies based on the content it ...

Vertex has established itself as a frontrunner in the indirect tax automation space, serving over 4,800 customers, including more than 60% of the Fortune 500. The company’s solutions are utilized in ...

On Wednesday, Raymond James analyst Brian Peterson maintained a Market Perform rating for Vertex (NASDAQ:VRTX) Inc. (NASDAQ:VERX), a tax software solutions provider with a market capitalization of ...

Vertex Minerals Limited (ASX:VTX) (OTCMKTS:VTXXF) is pleased to announce the purchase of an Aramine L350D Loader to be incorporated into the unde ...

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF ...